Dan Cheng1*, Yingxia Zhang1, Po Li1, Kaikai Cai1 and Weicheng Fei2
Received: October 19, 2022; Published: October 27, 2022
*Corresponding author: Dan Cheng, Research and Development Center, Lithy One Health Group, China
DOI: 10.32474/CTBM.2022.03.000154
In recent years, collagen peptides have been becoming the dominant products in the oral beauty market as various scientific researches have demonstrated they can stimulate the dermal fibroblasts that secrete various components such as collagen and elastin in the extracellular matrix. In our clinical study, 30 individuals were orally supplemented with a collagen peptide called Daily Glow® for 28 days, and the facial skin conditions including hydration, trans-epidermal water loss and elasticity were significantly and positively improved. Besides, it was clearly observed by the Antera 3D Miravex that redness and roughness were significantly improved. Our vitro test of human dermal fibroblast showed mRNA expression of MMP has been inhibited while mRNA expressions of LOX, FBN2 and AQP3 have been stimulated by Daily Glow®. This should be the first time that these mechanisms are newly proposed and demonstrated.
Skin appearance can indicate the age and health state by showing wrinkles, unevenly facial colors and black spot [1]. The fragmentation of the collagen matrix in the dermis occurs in an aged skin due to various reasons such as UV exposure [2]. However, the fragmented collagen originally produced and organized in fibroblasts cannot be reconnected because the synthesis of collagen and other extracellular matrix proteins are regulated by fibroblasts in response to mechanical tension that never exists during fragmentation [3]. Without the stretch of the collagen fibers, the fibroblasts not only produce insufficient amounts of collagen but also generate high level of collagen-degrading enzymes [4]. Therefore, the strategy of boosting the collagen synthesis by stimulating the damaged fibroblasts and its proliferation is preferred. Recently various human clinical trials have shown that orally administered collagen peptide is potential and beneficial in repairing the aged skin by stimulating the fibroblasts and collagen synthesis [5,6]. The mechanism lies in specific configurations of the unique triple helix structure with a repeating amino acid sequence of (glycine–X–Y) in collagen peptides. For instance, the structure of prolyl-hydroxyproline might function as chemotactic stimuli for fibroblasts in vivo and attract these cells to the damaged sites and tissues for restoration [7]. Besides, prolyl-hydroxyproline could also enhance proliferation human dermal fibroblasts as well as hyaluronic acid synthesis in a vitro study [8].
On the other hand, however, more mechanisms for collagen peptides supplement remains to be investigated. Matrix metalloproteinases (MMPs), a family of matrix protein–degrading enzymes, initiate the breakdown of collagen fibers [9]. Under UV exposure, the generation of reactive oxygen species lead to the overproduction of MMPs and subsequently photo-aging [10]. Various skin antioxidants are applied in order to scavenge those ROS [11]. In our study, we hypothesize that certain structures in the collagen peptides should be capable of inhibiting the activities of MMPs. Moreover, it should not be ignored that the transportation of water and glycerol in the basal layer keratinocytes of epidermis in normal skin cannot be finished without a membrane transporter called Aquaporin-3 (AQP3). It was found AQP3-knockout mice have reduced stratum corneum water content [12&13]. Here we also hypothesize the supplementation of collagen peptides could activate the expression of AQP3 and thus facilitate the hydration of epidermis. Therefore, in our investigation, not only did we conduct a human trial to demonstrate the effect a collagen peptide on the improvement of facial skin conditions, but also did we analyze the mechanisms of relative gene expressions in human dermal fibroblasts, which were contributed by the collagen peptide in a vitro study.
Daily Glow® was provided by Zhejiang Xinmei Biotechnology Co., Ltd. Fruit powders were formulated with Daily Glow® to form a total of 10 g powder product with favored taste.
This test was carried out with the assistance from Shanghai Huiwen Biotech Corp., Ltd. The solution of collagen peptide was prepared at 10%, 5%, 0.5%, 0.1% solution with sterile PBS. The solution of EGF (GIBCO) was prepared at 10 ng/ml solution with sterile PBS. The Human dermal fibroblast cells were inoculated (0.4 ~ 1.6x105 cells/well) into the 6-well cell culture plate with collagen peptides. The RNA extraction and reverse transcription cDNA were operated by the RNA extraction kit and Prime Script™ RT Master Mix. The primer verification of RT-PCR and RT-PCR tests (Table 1) were conducted by TB green ® Premix Ex Taq™ II (Takara).
The study was carried out as a single-blinded, randomized and self-controlled trial on the effects of 30 healthy male and female subjects after 14 and 28 days of oral intake. Thirty healthy female subjects in the age group of 27 to 39 years were screened and enrolled in the study. Twenty-five subjects completed the study and five withdrew due to personal reasons. They are capable of reading Chinese and comprehending the consent agreement; they are willing to cooperate and complete all the tests during the study and report any adverse events. The participants were supplemented with one sachet of Daily Glow® once a day. Before inception of the tests, all participants signed consent agreement that manifests their benefits from this test and relevant risks.
Females that are pregnant or breastfeeding; any obvious facial defects including sunburn, scar, pigmented nevus, which might impair the test characterization; facial microbial infections; chronic skin diseases (such as skin tumors, rosacea, eczema, lupus erythematosus, seborrheic dermatitis, psoriasis, severe epidermal shedding); history of immunosuppressive or immunodeficiency disorders (including HIV or AIDS) or current use of immunosuppressive drugs or radiotherapy; chronic and endocrine diseases such as asthma, epilepsy, diabetes, hypertension, hyperthyroidism or hypothyroidism; participation of other clinical studies during the past 3 months; took any drugs that may affect skin status or response in the past 6 months or currently such as antihistamines, antibiotics, insulin, anti-inflammatory drugs, vitamins A, steroids, aspirin, thyroid drug; treated with facial medical treatment, such as laser treatment, chemical stripping and minimally invasive cosmetic treatment; a history of mental illness or unable to take care of themselves; participant with any of the above were excluded from the study
All measurements were performed in the same room with no daylight under controlled ambient conditions (20°C-24°C, 48%- 50% relative humidity). Each subject was required to clean the face 30 minutes before the test.
The measuring principle of the Cutometer® MPA 580 (Figure 1) is based on the suction method, where negative pressure deforms the skin mechanically. Inside the probe, the penetration depth is determined by a non-contact optical measuring system. This optical measuring system consists of a light source and a light receptor, as well as two prisms facing each other, which project the light from transmitter to receptor. The light intensity varies due to the penetration depth of the skin. The resistance of the skin to the negative pressure (firmness) and its ability to return into its original position (elasticity) are displayed as curves (penetration depth in mm/time) in real time during the measurement. From these curves, parameters related to elastic and viscoelastic properties of skin surface can be calculated. The closer the value gets to 1, the more elastic the skin is.
The hydration level off the skin surface (stratum corneum) was characterized by Corneometer®, Derma Unit SSC 3 (Figure 2). The probe allows very quick measurement (1 s) that is crucial to avoid any Occlusion. Substances on the skin such salts or residues of topical applied products have only minimal impact due to capacitance measurement. Larger value reflects higher extent of hydration at skin surface.
The Terameter® TM 300 with its “open chamber” principle is worldwide accepted measuring device for the assessment of the trans-epidermal water loss (TEWL). This is an indispensable parameter for the evaluation of the water barrier function of the skin and a basic measurement in all kinds of applications. Even the slightest damage in the skin water barrier can be determined at an early stage (Figure 3). The Antera 3D is a camera for image acquisition and analysis of the skin, which relies on multi-directional illumination and computer-aided reconstruction of the skin surface from different angles. The skin topography and the chromophores’ concentration are derived from the spatial and spectral analysis of the acquired image data from skin illumination (Figure 4).
The safety and tolerability of the administration of treatment powder were evaluated at day 14 and day 28. Professional dermatologist asked the subjects whether they had gastrointestinal discomfort, body skin tingling, itching and other symptoms or obvious signs of dry skin, desquamation, flushing and so on. During the whole study, the participants were requested to report instantly to the investigator once they experienced any uncomfortable feelings.
Statistical analyses of this clinical study were completed using IBM Statistical Package for Social Sciences (SPSS 21.0) at an alpha level of 0.05. To evaluate primary and secondary outcome measures, analysis of variance (ANOVA) was used to compare within-group changes and group changes over time.
Figure 6: The fine lines and wrinkles of a subject at Day 0, 14 and 28 of Daily Glow® supplementation.
To investigate the effect of the collagen peptide on fibroblasts, various mRNA expressions are shown in (Table 2) and (Figure 5). The mRNA expression of AQP3 was increased when the concentration of collagen peptide increased from 0.01 to 1. The mRNA expressions of FBN2 and LOX were larger than those stimulated by EGF while they did not manifest in a dose-dependent manner. Besides, the mRNA expression of MMP1 was reduced as the concentrations of collagen peptide increased. It is not difficult to see at certain levels the effects of collagen peptides were comparable and even superior to those generated by EGF. The significant improvement of hydration, trans-epidermal water loss, elasticity, roughness and redness by supplementing Daily Glow® for 14 and 28 days are shown in (Tables 3&4). The significant improvement of fine lines, wrinkles and redness of the subjects’ facial skin after supplementing Daily Glow® for 14 and 28 are shown in (Figures 6&7).
There have been many animal and clinical research advances in the protection and improvement of skin by collagen peptides regarding skin elasticity, hydration, trans-epidermal water loss, photo aging, atopic skin and so on [14-16]. In our human trial, we observed the similar positive effects of collagen peptide administered to healthy subjects for 28 days. The skin conditions were improved from perspectives of skin hydration in the corneum, trans-epidermal water loss, skin elasticity, skin redness and skin roughness by professional instrumental characterization of facial skins. Collagen peptides can repair and increase the activity of fibroblasts and thus increase the production of hyaluronic acid and collagen fibrils [17]. In particular collagen tripeptides and di-peptides can stimulate the activity of fibroblasts with lost mechanical strength [18,19]. In our study, we investigated profoundly in the mechanisms of such effects. Firstly, under UVA exposure, a great amount of reactive oxygen species (ROS) would be generated under the skin, consequently increasing the production of matrix metalloproteinases (MMP), which is a group of protease enzymes responsible for the degradation of the extracellular matrix including collagen and elastin fibers [20]. In our vitro study, the mRNA expression of MMP1 was reduced when fibroblasts were co-cultured with Daily Glow®. As antioxidants could effectively scavenge ROS, formulas that contain both collagen peptide and antioxidants (e.g., plant-based SOD) could protect skin from a cascade of UV-exposed reactions [21]. In the futuristic research, the specific structure of the oligopeptides should be characterized and standardized regarding free radical scavenging capacities.
On the other hand, accumulating evidence indicates that the water-, glycerol- and hydrogen peroxide-transporting channel aquaporin-3 (AQP3) expressed in plasm membranes in a variety of cells plays a key role in various processes involved in keratinocyte function while abnormalities in this channel have been observed in several human skin diseases [22]. Hydration of the SC is an important determinant of skin appearance and highly depends on AQP3. Exposure of mice to high humidity or skin occlusion increased SC hydration in the wild type, but not in AQP3-null mice [23]. Also, it was found the magnitude of water moving into SC to off-set evaporative water is much lower than that with AQP3 [24]. In our research, the increased mRNA expression of AQP3 probably indicates the improvement in the SC hydration and trans-epidermal water loss. Both our vitro study and literature show certain structure in the collagen peptide should be similar with epidermal growth factor; however, this remains to be investigated in the futuristic studies [25]. One of the most significant components in extracellular matrix, elastic fibers are composed of elastin and microfibrils mainly structured with fibrillin (large cysteine-rich glycoproteins), which are encoded by distinct genes such as FBN2 [26]. Also, elastic fiber formation cannot be realized without lysyl oxidase (LOX), which plays a critical role in the catalysis of lysinederived crosslinks of elastin in the dermal extracellular matrix. In our vitro study, the mRNA expressions of FBN2 and LOX have been enhanced in human dermal fibroblasts stimulated by Daily Glow®. In general, our clinical study showed the administration of Daily Glow® to healthy subjects for 28 days significantly improved facial skin conditions in terms of elasticity, hydration, redness and so on. As various research has demonstrated the stimulation of collagen peptides on dermal fibroblasts, our vitro study should be the first scientific report that has verified the activation of several genes expressions by collagen peptides, which are extremely crucial for the fibroblasts to repair the skin.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...